2022
Anti-Mullerian Hormone Signaling: Relevance for Pathophysiology of PCOS and Implications for Novel Therapeutic Approaches to Managing Ovulatory Dysfunction of PCOS
Shapiro A, Kushnir V, Seifer D. Anti-Mullerian Hormone Signaling: Relevance for Pathophysiology of PCOS and Implications for Novel Therapeutic Approaches to Managing Ovulatory Dysfunction of PCOS. 2022, 511-525. DOI: 10.1007/978-3-030-92589-5_25.Peer-Reviewed Original ResearchPolycystic ovary syndromeAnti-Mullerian hormonePathophysiology of PCOSSerum anti-Mullerian hormoneElevated AMH levelsAvailable treatment modalitiesNovel therapeutic approachesFuture therapeutic targetsChronic anovulationOvulatory dysfunctionAMH levelsOvary syndromeOvulatory functionTreatment modalitiesNormal folliculogenesisTherapeutic approachesTherapeutic targetPatientsCritical roleAnovulationDysfunctionPathophysiologySyndromeFolliculogenesisHormone
1990
Current concepts of β-endorphin physiology in female reproductive dysfunction
Wallach E, Seifer D, Collins R. Current concepts of β-endorphin physiology in female reproductive dysfunction. Fertility And Sterility 1990, 54: 757-771. PMID: 2226908, DOI: 10.1016/s0015-0282(16)53928-4.Peer-Reviewed Original ResearchConceptsEndogenous opioid peptidesBeta-endorphinReproductive dysfunctionOpioid peptidesPulsatile GnRH releasePolycystic ovarian syndromeBeta-endorphin levelsFemale reproductive dysfunctionExercise-associated amenorrheaNormal menstrual cycleOnset of pubertyGnRH releaseOvarian syndromeMenstrual cyclePeripheral levelsDopaminergic pathwaysPathophysiological processesPulsatile releaseSpecific disordersDysfunctionParticular disorderCurrent conceptsPrecise mechanismAmenorrheaClinical application